Whalegun
Lobbying

On Demand Pharmaceuticals's latest lobbying report covers Q4 2025, at $30K. The four quarters Q3 2025–Q2 2026 total $70K. Its first report covers Q2 2024; the issues it reports most are Pharmacy and Budget/Appropriations.

On Demand Pharmaceuticals

Latest quarter
No record
Q2 2026 · 0 reports
Last 12 months
$70K
Last 4 quarters
vs last quarter
No record
Q2 2026 against the quarter before
First report
Q2 2024
The first quarter a report named it

Lobbying by quarter

On Demand Pharmaceuticals lobbying by quarter
On Demand Pharmaceuticals lobbying by quarter
QuarterAmountReports
Q2 2024$30K1
Q3 2024$10K1
Q4 2024$30K1
Q1 2025$30K1
Q2 2025$80K2
Q3 2025$40K3
Q4 2025$30K2
Q1 2026$00
Q2 2026$00

Policy issues the reports name

  • Pharmacy10 reports
  • Budget and appropriations4 reports

A report that names several issues counts once for each.

Who was lobbied

  • HOUSE OF REPRESENTATIVES10 reports
  • SENATE10 reports
  • Food & Drug Administration (FDA)2 reports
  • Health & Human Services, Dept of (HHS)2 reports
  • Executive Office of the President (EOP)1 reports
  • White House Office1 reports

Firms it paid

Firm
Omega Strategies$150K7 quarters
Black Diamond Strategies$50K2 quarters
Marble Arch$50K2 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
01/16for Q4 2025Omega Strategies$10K
01/07for Q4 2025Marble Arch$20K
25/10/20for Q3 2025Marble Arch$30K
25/10/17for Q3 2025Omega Strategies$10K
25/10/16for Q3 2025Black Diamond StrategiesUnder $5,000
25/08/14for Q3 2025Marble ArchUnder $5,000
25/07/21for Q2 2025Black Diamond Strategies$50K
25/07/21for Q2 2025Black Diamond StrategiesUnder $5,000
25/07/16for Q2 2025Omega Strategies$30K
25/04/18for Q1 2025Omega Strategies$30K
25/01/08for Q4 2024Omega Strategies$30K
24/10/08for Q3 2024Omega Strategies$10K
24/07/19for Q2 2024Omega Strategies$30K
24/05/15for Q2 2024Omega StrategiesUnder $5,000